CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
March 4, 2021—Qiagen announced the global launch of the CE-IVD-marked QIAcube Connect MDx, a flexible platform for automated sample processing available now to molecular diagnostic laboratories in the U.S., Canada, the European Union, and other markets worldwide.
QIAcube Connect MDx, for in vitro diagnostic applications, offers two software environments–IVD mode for validated IVD applications and research mode—and can be used in combination with the company’s QIAamp DSP kits and PAXgene Blood RNA extraction kits. The system fully automates the lysis, bind, wash, and elute steps of the Qiagen spin columns, which can also be used manually, for DNA, RNA, and protein sample processing.
Pages: 1 2